Disease-causing mutations of GLIALCAM are associated with a phenotypic spectrum including macrocephaly, leukoencephalopathy, and epilepsy, with or without autism, as well as intellectual disability and psychomotor deterioration. The gene discussed is HEPACAM; the disease is Leukoencephalopathy.